Inventor

NORRIS DEREK J

US31 patents

⚠️ This page may combine multiple inventors who share the name “NORRIS DEREK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NORRIS DEREK J

BRISTOL MYERS SQUIBB CO

Cyclic protein tyrosine kinase inhibitors

Cyclic protein tyrosine kinase inhibitors

Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors

Cyclic protein tyrosine kinase inhibitors

Cyclic protein tyrosine kinase inhibitors

Tricyclic compounds as anticancer agents

Cyclic protein tyrosine kinase inhibitors

Cyclic protein tyrosine kinase inhibitors

Imidazoquinoxaline protein tyrosine kinase inhibitors

Pyrrolotriazine compounds as kinase inhibitors

Pyrrolotriazine compounds as kinase inhibitors

Di-substituted pyrrolotriazine compounds

Carbazole compounds useful as bromodomain inhibitors

Tricyclic compounds as anticancer agents

Process for preparing pyrrolotriazine

Pyrrolotriazine compounds as kinase inhibitors

Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Tricyclic compounds as anticancer agents

Tricyclic compounds as anticancer agents

Uracil derivatives as Mer-AXL inhibitors

Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith

Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith

Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds

INNATE TUMOR IMMUNITY INC

NLRP3 modulators

NLRP3 modulators

ACIC CANADA INC

Methods for the manufacture of fluconazole

Commercial process for the manufacture of fluconazole and intermediates useful in the manufacture thereof

DAS JAGABANDHU

Cyclic protein tyrosine kinase inhibitors

WEI CHENKOU

Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol

NORRIS DEREK J

Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function